Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)

Documenti analoghi

• Advances in 5‐Ene‐2,4‐thiazolidinediones Research: Multifaceted Biological Profile, Structure–Activity Relationship, and Mechanisms of Action
  di: Neeru Malik, et al.
  Pubblicazione: (2025)
• Design, Synthesis, and Pharmacological Evaluation of Prenylated Arylidene‐Substituted Thiazolidinedione‐Based Pancreatic Lipase Inhibitors as Anti‐obesity Agents
  di: Rakesh Khator, et al.
  Pubblicazione: (2025)
• Designing Telomerase Inhibitors for Cancer Therapy: Mechanistic Insights, Medicinal Chemistry Strategies, Challenges, and Future Directions
  di: Ahmed A. Al‐Karmalawy, et al.
  Pubblicazione: (2026)
• Synthesis of Promising Biguanide Derivatives Bearing Urea/Thiourea as Type II Antidiabetic Agents
  di: Wahid M. Basyouni, et al.
  Pubblicazione: (2025)
• Harnessing Fragment Merging and Chain Extension Approaches for Designing Phthalimidoalkyl‐Arylidene Thiazolidinedione Hybrids: New Frontiers in Apoptosis‐Inducing Cancer Treatment
  di: Saad Shaaban, et al.
  Pubblicazione: (2025)